Global fibrinolytic capacity in patients with subclinical hypothyroidism
dc.authorwosid | Turgut, Burhan/A-2517-2016 | |
dc.contributor.author | Guldiken, S | |
dc.contributor.author | Demir, M | |
dc.contributor.author | Turgut, B | |
dc.contributor.author | Altun, BU | |
dc.contributor.author | Arikan, E | |
dc.contributor.author | Kara, M | |
dc.date.accessioned | 2024-06-12T11:15:46Z | |
dc.date.available | 2024-06-12T11:15:46Z | |
dc.date.issued | 2005 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Subclinical hypothyroidism (SH) represents the earliest stages of hypothyroidism but the benefits of detecting and treating SH are not well known. The aim of this Study was to evaluate the alterations in global fibrinolytic capacity (GFC), which indicates the overall fibrinolytic activity, in patients with SH. The study group comprised of 15 patients with SH and 15 healthy controls. The GFC was significantly lower in patients with SH than in control group (p < 0.002). This result suggests a relative hypercoagulable state in SH. | en_US |
dc.identifier.doi | 10.1507/endocrj.52.363 | |
dc.identifier.endpage | 367 | en_US |
dc.identifier.issn | 0918-8959 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 16006731 | en_US |
dc.identifier.scopus | 2-s2.0-22344452880 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 363 | en_US |
dc.identifier.uri | https://doi.org/10.1507/endocrj.52.363 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/24066 | |
dc.identifier.volume | 52 | en_US |
dc.identifier.wos | WOS:000230338000010 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Japan Endocrine Society | en_US |
dc.relation.ispartof | Endocrine Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Subdinical Hypothyroidism | en_US |
dc.subject | Global Fibrinolytic Capacity | en_US |
dc.subject | Hypothyroidism | en_US |
dc.subject | Fibrinolytic System | en_US |
dc.subject | Thyroid-Disease | en_US |
dc.subject | Risk-Factor | en_US |
dc.subject | Cardiovascular-Disease | en_US |
dc.subject | Myocardial-Infarction | en_US |
dc.subject | Hemostatic System | en_US |
dc.subject | Plasma | en_US |
dc.subject | State | en_US |
dc.subject | Atherosclerosis | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Markers | en_US |
dc.title | Global fibrinolytic capacity in patients with subclinical hypothyroidism | en_US |
dc.type | Article | en_US |